Skip to content

Corporate

The $1,000 Genome

Staggering reduction in cost will help revolutionize medicine

Recent Articles

The Diagnostic Odyssey
The Diagnostic Odyssey
Illumina Perspective on the Novel Coronavirus SARS-CoV-2 (2019-nCoV) Outbreak:
Illumina Perspective on the Novel Coronavirus SARS-CoV-2 (2019-nCoV) Outbreak:
Patients With Challenging Cancers to Benefit from Genomic Sequencing
Patients With Challenging Cancers to Benefit from Genomic Sequencing